Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Urologic Neoplasms 2 Stomach Neoplasms 2 Brain Neoplasms 2 beta-Thalassemia 1 Urinary Bladder Neoplasms 1 Supratentorial Brain Tumor Surgery 1 Strabismus 1 Prostatic Neoplasms 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Postoperative Complications 1 Post-operative Residual Curarization 1 Obesity 1 Neuromuscular Blockade 1 Neoplasms 1 Myasthenia Gravis 1 Hepatoblastoma 1 Endobronchial Metastases 1 Emergence Delirium 1 Delayed Emergence from Anesthesia 1

Interventions

Docetaxel 171 Radiotherapy 144 Magnetic Resonance Spectroscopy 142 Leuprolide 112 Prednisone 108 enzalutamide 102 Radiosurgery 101 Abiraterone Acetate 94 Androgen Antagonists 91 Goserelin 83 bicalutamide 81 gallium 68 PSMA-11 70 Surveys and Questionnaires 63 apalutamide 57 Specimen Handling 56 acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 55 Radiation 47 Gonadotropin-Releasing Hormone 45 Standard of Care 44 Biopsy 44 Brachytherapy 42 Radiotherapy, Intensity-Modulated 40 Blood Specimen Collection 40 darolutamide 39 abiraterone 39 cabazitaxel 35 Exercise 35 Carboplatin 33 Pluvicto 32 Triptorelin Pamoate 31

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Prostatic Neoplasms × Sugammadex × Clear all

NCT04854993 2023-01-25

RECIR

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Phase 3 Completed

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡